Cargando…

Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer

INTRODUCTION: Aromatase inhibitors (AIs) dramatically increased breast cancer (BC) survival, leading to enhanced attention to their long-term consequences on psychological functioning. Conflicting data has been examined regarding the association between AIs administration and the clinical psychologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martino, Gabriella, Catalano, Antonino, Agostino, Rita Maria, Bellone, Federica, Morabito, Nunziata, Lasco, Carmen Giulia, Vicario, Carmelo Mario, Schwarz, Peter, Feldt-Rasmussen, Ulla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098625/ https://www.ncbi.nlm.nih.gov/pubmed/32214378 http://dx.doi.org/10.1371/journal.pone.0230681

Ejemplares similares

Anxiety Levels Predict Bone Mineral Density in Postmenopausal Women Undergoing Oral Bisphosphonates: A Two-Year Follow-Up
por: Martino, Gabriella, et al.
Publicado: (2021)

As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration
por: Martino, Gabriella, et al.
Publicado: (2019)

Interrelations between clinical-psychological features and bone mineral density changes in post-menopausal women undergoing anti-osteoporotic treatment: a two-year follow-up
por: Martino, Gabriella, et al.
Publicado: (2023)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
por: Bellone, Federica, et al.
Publicado: (2021)

Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis
por: Catalano, Antonino, et al.
Publicado: (2021)

Sclerostin and Vascular Pathophysiology
por: Catalano, Antonino, et al.
Publicado: (2020)

SUN-343 Prevalence and Incidence of Hypomagnesemia and Hypermagnesemia in Medical Settings
por: Catalano, Antonino, et al.
Publicado: (2020)

Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients?
por: Lasco, Antonino, et al.
Publicado: (2012)

Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience
por: Gaudio, Agostino, et al.
Publicado: (2019)

The Relationship Between Alexithymia and Type 2 Diabetes: A Systematic Review
por: Martino, Gabriella, et al.
Publicado: (2020)

Alexithymia, Emotional Distress, and Perceived Quality of Life in Patients With Hashimoto’s Thyroiditis
por: Martino, Gabriella, et al.
Publicado: (2021)

Going Beyond the Visible in Type 2 Diabetes Mellitus: Defense Mechanisms and Their Associations With Depression and Health-Related Quality of Life
por: Martino, Gabriella, et al.
Publicado: (2020)

Trabecular bone score and phalangeal quantitative ultrasound are associated with muscle strength and fracture risk in hemodialysis patients
por: Catalano, Antonino, et al.
Publicado: (2022)

Vitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome
por: Di Bari, Flavia, et al.
Publicado: (2021)

Editorial: Psychological Factors as Determinants of Medical Conditions
por: Martino, Gabriella, et al.
Publicado: (2019)

An unusual bilateral groin pain after COVID-19 infection in an 82-year-old man
por: Bellone, Federica, et al.
Publicado: (2023)

Editorial: Psychological Factors as Determinants of Medical Conditions, Volume II
por: Caputo, Andrea, et al.
Publicado: (2022)

Alexithymia and asthma: a systematic review
por: Silvestro, Orlando, et al.
Publicado: (2023)

Alexithymia and Inflammatory Bowel Disease: A Systematic Review
por: Martino, Gabriella, et al.
Publicado: (2020)

A Quantum–Classical Model of Brain Dynamics
por: Sergi, Alessandro, et al.
Publicado: (2023)

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients
por: Bertelsen, Bjørn-Erik, et al.
Publicado: (2021)

Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy
por: Pedersini, Rebecca, et al.
Publicado: (2019)

Dopamine and serotonin in fear extinction: some key questions to be addressed
por: Vicario, Carmelo M, et al.
Publicado: (2020)

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

Clinical Utility of Aromatase Inhibitors as Adjuvant Treatment in Postmenopausal Early Breast Cancer
por: Loaiza-Bonilla, Arturo, et al.
Publicado: (2013)

Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors
por: Hong, Dongsheng, et al.
Publicado: (2017)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
por: Cairns, Junmei, et al.
Publicado: (2020)

Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer
por: Chen, Han, et al.
Publicado: (2020)

Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis
por: Chen, Shanshan, et al.
Publicado: (2022)

Radioiodine treatment for non-toxic goitre
por: Feldt-Rasmussen, Ulla
Publicado: (2009)

Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences
por: Russo, Giuseppina T., et al.
Publicado: (2016)

Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences”
por: Russo, Giuseppina T., et al.
Publicado: (2017)

Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers.
por: Yates, R. A., et al.
Publicado: (1996)

Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women
por: Goss, Paul E, et al.
Publicado: (2007)

Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
por: Gonnelli, Stefano, et al.
Publicado: (2008)

Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial
por: Lomax, Anna J., et al.
Publicado: (2013)

Ovarian mucinous adenocarcinoma with functioning stroma in postmenopausal women: aromatase and SF-1 expressions
por: Hattori, Yuka, et al.
Publicado: (2015)

Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

Higher Insulin Resistance and Adiposity in Postmenopausal Women With Breast Cancer Treated With Aromatase Inhibitors
por: Gibb, Fraser W, et al.
Publicado: (2019)

Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing?
por: Catalano, A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a0kg69bn37pfn0npmv8ams7jo2